Xencor reported $7.25M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
AstraZeneca USD 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Cytokinetics USD 13M 700K Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Xencor USD 7.25M 290K Jun/2025